Assessment of Expected Drug Exposure Relative Maximum Safety Limits in Early Phase Studies

MIDD

Trial design and analysis

Pharmacometrics

Program strategies and efficiencies

PAGE 28 (2019) Abstr 9159.

Kristoffersson A, Röshammar D, Plan EL